The latest closing stock price for Pieris Pharmaceuticals as of September 18, 2024 is 16.16.
An investor who bought $1,000 worth of Pieris Pharmaceuticals stock at the IPO in 2015 would have $-945 today, roughly -1 times their original investment - a -27.50% compound annual growth rate over 9 years.
The all-time high Pieris Pharmaceuticals stock closing price was 756.00 on February 13, 2018.
The Pieris Pharmaceuticals 52-week high stock price is 27.20, which is 68.3% above the current share price.
The Pieris Pharmaceuticals 52-week low stock price is 6.20, which is 61.6% below the current share price.
The average Pieris Pharmaceuticals stock price for the last 52 weeks is 14.71.
An investor who bought $1,000 worth of Pieris Pharmaceuticals stock at the IPO in 2015 would have $-945 today, roughly -1 times their original investment - a -27.50% compound annual growth rate over 9 years.
The all-time high Pieris Pharmaceuticals stock closing price was 756.00 on February 13, 2018.
The Pieris Pharmaceuticals 52-week high stock price is 27.20, which is 68.3% above the current share price.
The Pieris Pharmaceuticals 52-week low stock price is 6.20, which is 61.6% below the current share price.
The average Pieris Pharmaceuticals stock price for the last 52 weeks is 14.71.